真实世界-话题@MedSci

#真实世界#

277篇内容 | 5722人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1295196, encodeId=04dd129519696, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=你应该了解的“真实世界研究”, objectType=article, longId=133308, objectId=dc8e133308f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc8e133308f2, replyNumber=0, likeNumber=78, createdTime=2018-03-25, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc8e133308f2, moduleTitle=你应该了解的“真实世界研究”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc8e133308f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295195, encodeId=5b831295195e4, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=真实世界的数据支持赛诺菲的Toujeo用于I型糖尿病, objectType=article, longId=133029, objectId=7d8913302977, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d8913302977, replyNumber=0, likeNumber=74, createdTime=2018-03-22, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d8913302977, moduleTitle=真实世界的数据支持赛诺菲的Toujeo用于I型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d8913302977)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295194, encodeId=409f12951940e, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=真实世界研究表明：通络药物治疗心血管病现曙光, objectType=article, longId=132768, objectId=9831132e68e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9831132e68e5, replyNumber=0, likeNumber=75, createdTime=2018-03-19, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9831132e68e5, moduleTitle=真实世界研究表明：通络药物治疗心血管病现曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9831132e68e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295193, encodeId=cf32129519321, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=梅斯医学——助力您的真实世界研究, objectType=article, longId=132649, objectId=5a5513264912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5513264912, replyNumber=0, likeNumber=53, createdTime=2018-03-18, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5513264912, moduleTitle=梅斯医学——助力您的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5513264912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295192, encodeId=f244129519250, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Dig Liver Dis：真实世界中，OBT/PTV-r+RBV治疗HCV基因4型（进展期肝纤维化）患者，疗效良好，可获得较高SVR, objectType=article, longId=131797, objectId=3b1b131e97fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1b131e97fa, replyNumber=0, likeNumber=80, createdTime=2018-03-09, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1b131e97fa, moduleTitle=Dig Liver Dis：真实世界中，OBT/PTV-r+RBV治疗HCV基因4型（进展期肝纤维化）患者，疗效良好，可获得较高SVR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b1b131e97fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295191, encodeId=54c91295191b0, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究, objectType=article, longId=129880, objectId=62cb12988029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cb12988029, replyNumber=0, likeNumber=64, createdTime=2018-02-15, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cb12988029, moduleTitle=Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cb12988029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295190, encodeId=1f931295190d9, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Dig Liver Dis：老年直肠癌的放射治疗:十年的真实世界数据评估, objectType=article, longId=129518, objectId=036a129518d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036a129518d3, replyNumber=0, likeNumber=68, createdTime=2018-02-11, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036a129518d3, moduleTitle=Dig Liver Dis：老年直肠癌的放射治疗:十年的真实世界数据评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036a129518d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295189, encodeId=e3e71295189f7, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=中国真实世界证据论文荣登BMJ“中国专辑”, objectType=article, longId=129366, objectId=f0f71293660f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0f71293660f, replyNumber=0, likeNumber=100, createdTime=2018-02-10, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0f71293660f, moduleTitle=中国真实世界证据论文荣登BMJ“中国专辑”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0f71293660f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295188, encodeId=c31612951883b, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=真实世界研究：达比加群酯与利伐沙班相比主要出血风险相似, objectType=article, longId=128111, objectId=4b0f128111d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b0f128111d8, replyNumber=0, likeNumber=69, createdTime=2018-01-31, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b0f128111d8, moduleTitle=真实世界研究：达比加群酯与利伐沙班相比主要出血风险相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b0f128111d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295187, encodeId=ec3c129518ef7, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？, objectType=article, longId=124969, objectId=962b12496943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=962b12496943, replyNumber=0, likeNumber=48, createdTime=2017-12-30, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=962b12496943, moduleTitle=Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=962b12496943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295186, encodeId=d039129518662, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Diabet Med：糖尿病患者预混、基础胰岛素方案的临床结局数据：RCT vs真实世界, objectType=article, longId=124801, objectId=66861248016f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66861248016f, replyNumber=0, likeNumber=60, createdTime=2017-12-28, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66861248016f, moduleTitle=Diabet Med：糖尿病患者预混、基础胰岛素方案的临床结局数据：RCT vs真实世界, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66861248016f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295185, encodeId=fb00129518507, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=中国临床医学真实世界研究施行规范, objectType=article, longId=124744, objectId=04c2124e44ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04c2124e44ff, replyNumber=0, likeNumber=75, createdTime=2017-12-28, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04c2124e44ff, moduleTitle=中国临床医学真实世界研究施行规范, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04c2124e44ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295184, encodeId=f6251295184bc, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=Stroke：真实世界中PFO闭合术围手术期严重并发症或死亡比例为1/14, objectType=article, longId=123630, objectId=95e412363071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95e412363071, replyNumber=0, likeNumber=26, createdTime=2017-12-17, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95e412363071, moduleTitle=Stroke：真实世界中PFO闭合术围手术期严重并发症或死亡比例为1/14, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95e412363071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295183, encodeId=9571129518349, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=武田发布8项Entyvio®（维多珠单抗）真实世界的积极药物数据, objectType=article, longId=122550, objectId=27ef122550da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ef122550da, replyNumber=0, likeNumber=0, createdTime=2017-12-08, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ef122550da, moduleTitle=武田发布8项Entyvio®（维多珠单抗）真实世界的积极药物数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27ef122550da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295182, encodeId=8dc61295182b6, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=真实世界数据：诺华Entresto®可改善心衰患者生存质量, objectType=article, longId=121203, objectId=27d6121203dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d6121203dd, replyNumber=0, likeNumber=89, createdTime=2017-11-25, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d6121203dd, moduleTitle=真实世界数据：诺华Entresto®可改善心衰患者生存质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d6121203dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295181, encodeId=dbf41295181a3, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=肺栓塞新型口服抗凝药拜瑞妥®在华上市相关真实世界研究回顾, objectType=article, longId=121072, objectId=789e1210e23b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=789e1210e23b, replyNumber=0, likeNumber=62, createdTime=2017-11-24, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=789e1210e23b, moduleTitle=肺栓塞新型口服抗凝药拜瑞妥®在华上市相关真实世界研究回顾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=789e1210e23b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295180, encodeId=0c19129518098, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=【AHA2017】真实世界数据挑战临床试验结果：新型P2Y12抑制剂真的优于氯吡格雷？, objectType=article, longId=120654, objectId=cd061206549f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd061206549f, replyNumber=0, likeNumber=58, createdTime=2017-11-20, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd061206549f, moduleTitle=【AHA2017】真实世界数据挑战临床试验结果：新型P2Y12抑制剂真的优于氯吡格雷？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd061206549f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295179, encodeId=5dd112951e917, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=乳腺癌化疗精准之路，真实世界研究指明前进方向！, objectType=article, longId=117200, objectId=170811e20099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=170811e20099, replyNumber=0, likeNumber=69, createdTime=2017-10-24, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=170811e20099, moduleTitle=乳腺癌化疗精准之路，真实世界研究指明前进方向！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=170811e20099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295178, encodeId=f78712951e86a, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=【2017 CSCO】重磅宣布中国版真实世界研究指南发布在即, objectType=article, longId=114983, objectId=2714114983d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2714114983d6, replyNumber=0, likeNumber=66, createdTime=2017-10-02, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2714114983d6, moduleTitle=【2017 CSCO】重磅宣布中国版真实世界研究指南发布在即, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2714114983d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1295177, encodeId=e6d512951e780, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, objectTitle=真实世界证据推进公共卫生发展, objectType=article, longId=114294, objectId=4b1e11429482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b1e11429482, replyNumber=0, likeNumber=68, createdTime=2017-09-28, rootId=0, userName=chenshujs, userId=5b34252, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b1e11429482, moduleTitle=真实世界证据推进公共卫生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b1e11429482)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

真实世界

2020-05-29

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

你应该了解的“真实世界研究”

2018-03-25

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

真实世界的数据支持赛诺菲的Toujeo用于I型糖尿病

2018-03-22

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

真实世界研究表明：通络药物治疗心血管病现曙光

2018-03-19

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

梅斯医学——助力您的真实世界研究

2018-03-18

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Dig Liver Dis：真实世界中，OBT/PTV-r+RBV治疗HCV基因4型（进展期肝纤维化）患者，疗效良好，可获得较高SVR

2018-03-09

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究

2018-02-15

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Dig Liver Dis：老年直肠癌的放射治疗:十年的真实世界数据评估

2018-02-11

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

中国真实世界证据论文荣登BMJ“中国专辑”

2018-02-10

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

真实世界研究：达比加群酯与利伐沙班相比主要出血风险相似

2018-01-31

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？

2017-12-30

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Diabet Med：糖尿病患者预混、基础胰岛素方案的临床结局数据：RCT vs真实世界

2017-12-28

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

中国临床医学真实世界研究施行规范

2017-12-28

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

Stroke：真实世界中PFO闭合术围手术期严重并发症或死亡比例为1/14

2017-12-17

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

武田发布8项Entyvio®（维多珠单抗）真实世界的积极药物数据

2017-12-08

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

真实世界数据：诺华Entresto®可改善心衰患者生存质量

2017-11-25

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

肺栓塞新型口服抗凝药拜瑞妥®在华上市相关真实世界研究回顾

2017-11-24

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

【AHA2017】真实世界数据挑战临床试验结果：新型P2Y12抑制剂真的优于氯吡格雷？

2017-11-20

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

乳腺癌化疗精准之路，真实世界研究指明前进方向！

2017-10-24

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

【2017 CSCO】重磅宣布中国版真实世界研究指南发布在即

2017-10-02

chenshujs (审核中...)

前往app查看评论内容

#真实世界#

真实世界证据推进公共卫生发展

2017-09-28

科室
- - 订阅+
  - 更多科室
工具
服务